Upfront Docetaxel in the Post-STAMPEDE World: Lessons from an Early Evaluation of Non-trial Usage in Hormone-Sensitive Prostate Cancer.

View/Open

Accepted version (14.62Kb)

Publication Date

2017-10

ICR Author

Dearnaley, David

Eeles, Rosalind

Huddart, Robert

Attard, Gerhardt

Parker, Chris

van As, Nick

Tree, Alison

Marsden,

Author

Patrikidou, A

Uccello, M

Tree, A

Parker, C

Attard, G

Eeles, R

Khoo, V

van As, N

Huddart, R

Dearnaley, D

Reid, A

Type

Journal Article

Metadata

Show full item record

URL

https://repository.icr.ac.uk/handle/internal/706

Collections

• Genetics and Epidemiology
• Molecular Pathology
• Radiotherapy and Imaging

Licenseref URL

http://www.rioxx.net/licenses/all-rights-reserved

Version of record

10.1016/j.clon.2017.06.006

Research team

Treatment Resistance

Clinical Academic Radiotherapy (Dearnaley)

Clinical Academic Radiotherapy (Huddart)

Oncogenetics

Stereotactic and Precision Body Radiotherapy

Language

eng

Date accepted

2017-06-06

License start date

2017-10

Citation

Clin Oncol (R Coll Radiol), 2017, 29 (10), pp. e174 - e175